Appeals by Allergan, Advanz Pharma, other drugmakers and two private equity firms against UK decisions over anticompetitive drug pricing and market sharing will be heard in separate batches, a judge has ruled.
The Competition Appeal Tribunal today sought to iron out hearing schedules for the appeals, which focus on two decisions by